Test of a new breathing interface for COPD flare-ups
Part of Lungs & breathing clinical trials.
This study compares a new breathing interface (“DUET”) with the usual interface for people with COPD who are having an acute flare-up and higher-than-normal carbon dioxide levels. It aims to see whether the new interface helps you breathe better and recover more safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You currently have a COPD flare-up with worsening breathing symptoms beyond your usual day-to-day changes, needing medication changes.
- You have a mild-to-moderate acute breathing problem related to too much carbon dioxide (as shown on blood tests).
- This is not your usual long-term (chronic) breathing failure worsening—your team must consider it a new, acute event.
- You do not have urgent signs that you need a breathing tube right away (for example, very low consciousness, arrest, or inability to protect your airway).
- You do not have major issues that prevent safe use of the device, like severe facial injury/burns or a fixed blockage in the upper airway.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is looking at patients with a serious worsening of their chronic obstructive pulmonary disease (COPD) who need intensive care. It aims to gather information to help improve treatment for these severe episodes.
This trial studies how different breathing support strategies affect people with COPD who have high carbon dioxide (CO2) in their blood. It may help care teams choose safer respiratory support after a breathing machine is stopped.
This trial compares different breathing strategies for people with COPD who still have high carbon dioxide levels in their blood a few weeks after a severe flare-up. The goal is to find the best way to help you breathe easier and improve your oxygen levels.
This trial tests whether a special type of oxygen delivered through the nose (high-flow nasal oxygen) helps people hospitalized for a COPD flare-up. It is likely meant for people with significant breathing problems and recent repeat flare-ups.
This study compares two different types of inhaled breathing treatments given in the emergency department for a sudden COPD flare-up. One treatment is long-acting (works longer) and the other is short-acting (works faster but wears off sooner). The goal is to see which one helps patients breathe better and recover faster.
This trial compares two types of high flow nasal cannula to see which one makes it easier for you to breathe. You may join if you are 18 or older and have normal oxygen levels without extra oxygen.
Hear when a new COPD Exacerbation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.